Applications of nanotechnology for immunology

被引:0
|
作者
Douglas M. Smith
Jakub K. Simon
James R. Baker Jr
机构
[1] Michigan Nanotechnology Institute for Medicine and Biological Sciences,Department of Internal Medicine
[2] University of Michigan Medical School,undefined
[3] University of Michigan Medical School,undefined
[4] NanoBio Corporation,undefined
来源
Nature Reviews Immunology | 2013年 / 13卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Nanotechnology makes use of the unique properties of objects that function as a unit within the overall size range of 1 to 1,000 nanometres, which is on the same scale as for many biological structures such as antigens, receptors, subcellular components of the immune system and microbes. The engineering of nanoscale compounds by the modification of properties such as nanoparticle size, shape, charge, porosity, surface area and hydrophobicity holds great promise for the development of immune response modulators and vaccines.The enhancement of the immune response by nanoparticles can be achieved through innate immune potentiation or by the enhanced delivery of antigens. Virus-like particles activate the innate immune response via Toll-like receptors and the repetitive display of antigens, whereas nanogels and cationic liposomes are examples of vaccine carriers.The molecular pathways involved in immune activation by nanoparticles are diverse and might include the upregulation of homing receptors such as CC-chemokine receptor 7, co-stimulatory molecules including CD40, CD80 and CD86, as well as increased cytokine production. Enhanced delivery by nanoparticles might induce apoptosis or necrosis.The suppression of the immune response can be achieved through direct immunosuppression or by the delivery of immunosuppressants. Fullerenes have a direct immunosuppressive effect but can also deliver immunosuppressive drugs, as can dendrimers, polymers, and liposomes.The molecular pathways involved in immunosuppression might include increased expression of cyclooxygenase 2, prostangandin E2 and interleukin-10 (IL-10), and apoptosis. The delivery of immunosuppressants results in a decreased response to IL-2 with sirolimus, in the downregulation of nuclear factor-kB with steroids, and in the upregulation of forkhead box P3 (FOXP3), which causes an increased regulatory T cell activity when self antigens are presented.Nanotechnology will continue to provide remarkable insights into the nature of the immune response. The application of nanotechnology to immunology might also affect new strategies to prevent or to treat human diseases.
引用
收藏
页码:592 / 605
页数:13
相关论文
共 50 条
  • [1] Applications of nanotechnology for immunology
    Smith, Douglas M.
    Simon, Jakub K.
    Baker, James R., Jr.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2013, 13 (08) : 592 - 605
  • [2] Erratum: Applications of nanotechnology for immunology
    Douglas M. Smith
    Jakub K. Simon
    James R. Baker Jr
    [J]. Nature Reviews Immunology, 2013, 13 : 701 - 701
  • [3] Emerging applications of nanotechnology in context to immunology: A comprehensive review
    Mobeen, Hifsa
    Safdar, Muhammad
    Fatima, Asma
    Afzal, Samia
    Zaman, Hassan
    Mehdi, Zuhair
    [J]. FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2022, 10
  • [4] Applications of nanotechnology for immunology (vol 13, pg 592, 2013)
    Smith, Douglas M.
    Simon, Jakub K.
    Baker, James R., Jr.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2013, 13 (09) : 701 - 701
  • [5] Role for immunology in nanotechnology
    Erlanger, BF
    Chen, BX
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U954 - U954
  • [6] Nanotechnology in vaccine and immunology
    Sonali
    Rawat, Amisha
    Yadav, Monika
    [J]. INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, 2022, 59 (12): : 1135 - 1143
  • [7] Nanotechnology: potential tool for immunology
    Aslam, Bilal
    Nisar, Muhammad A.
    Khurshid, Mohsin
    Muzammil, Saima
    Hayat, Sumreen
    [J]. PANMINERVA MEDICA, 2017, 59 (03) : 277 - 278
  • [8] Size Matters - Nanotechnology and Therapeutics in Rheumatology and Immunology
    Henderson, Carl S.
    Madison, Andrew C.
    Shah, Ankoor
    [J]. CURRENT RHEUMATOLOGY REVIEWS, 2014, 10 (01) : 11 - 21
  • [9] Nanotechnology update: potential nanotechnology applications
    不详
    [J]. FOOD AUSTRALIA, 2010, 62 (03): : 78 - 79
  • [10] Medical applications of nanotechnology
    Zdrojewicz, Zygmunt
    Waracki, Mateusz
    Bugaj, Bartosz
    Pypno, Damian
    Cabala, Krzysztof
    [J]. POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2015, 69 : 1196 - 1204